Public Calendar: February 7-13, 2021
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Janet Woodcock, M.D., Acting Commissioner
Event Date: 02/11/2021
Location: Virtual
Subject: Trust for America's Health Multisector COVID Coalition Meeting
FDA Participant/Group: DAYLE CRISTINZIO; BETH FRITSCH; PETER MARKS;
Non FDA Participant/Group: Industry, government, and other invited guests
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
Event Date: 02/11/2021
Location: Virtual
Subject: American Society of Nephrologists (ASN) Capital Markets Day for Kidney Health; Panelist: Developing an Innovation Substrate that Supports Appropriate Regulatory and Payment Policies for Kidney Health
FDA Participant/Group: JEFFREY SHUREN;
Non FDA Participant/Group: Government, industry, and other stakeholders
Official Name: Erika Anderson, Acting Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 02/08/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; JEFFREY FARRAR; CAITLIN BOON;
Non FDA Participant/Group: Barb Glenn, Bob Ehart, Joe Reardon, RJ Karney, Zach Gihorski (National Association of State Departments of Agriculture);
Event Date: 02/11/2021
Location: Virtual
Subject: New Era of Smarter Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Several executives and staff from across the food industry, academia, and government
Event Date: 02/11/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from the Consumer Brands Association, scientific and technical staff from industry
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 02/08/2021
Location: Virtual
Subject: Disease Prevention and Control Summit Group Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the Disease Prevention and Control Summit Group
Event Date: 02/11/2021
Location: Virtual
Subject: Friends of Cancer Research - Shaping the Future of Emerging Immunotherapies and Cell Therapies Meeting; Panelist: Shaping the Future of Cell Therapies - 2021 and Beyond
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Event Date: 02/11/2021
Location: Virtual
Subject: Ax-S Pharma Thursdays e-Conference Series; Panelist: The 2020 Report Card on Pre-Market Access to COVID-19 Diagnostics, Therapeutics, and Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Event Date: 02/11/2021
Location: Virtual
Subject: We’re Organizing Research on Lysosomal Diseases (WORLD) Symposium Scientific Meeting; Keynote Speaker: Trailblazing a Regulatory Framework for Individualized Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Acting Chief Counsel
No Significant Event